Hepatitis C Hepatitis C  In countries where there is an insufficient supply of sterile syringes, medications should be given orally rather than via injection .  Recent research also suggests that treating people with active infection, thereby reducing the potential for transmission, may be an effective preventive measure. Hepatitus C vaccine phase 1 clinical trials are set to begin in the summer of 2023.  Those with chronic hepatitis C are advised to avoid alcohol and medications that are toxic to the liver.  They should also be vaccinated against hepatitis A and hepatitis B due to the increased risk if also infected.  Use of acetaminophen is generally considered safe at reduced doses.  Nonsteroidal anti-inflammatory drugs  are not recommended in those with advanced liver disease due to an increased risk of bleeding Hepatitis C Hepatitis C